Earnings Feed
Start Free
|4/AFeb 12, 7:43 PM ET

BIOJECT MEDICAL TECHNOLOGIES INC 4/A

4/A · BIOJECT MEDICAL TECHNOLOGIES INC · Filed Feb 12, 2010

Insider Transaction Report

Form 4/AAmended
Period: 2009-12-31
BIOJECT MEDICAL TECHNOLOGIES INCBJCT
FARRELL CHRISTINE
VP of Finance
Transactions
  • Exercise/Conversion

    BJCT Common Stock

    2009-12-31+25,000→ 254,024 total
  • Exercise/Conversion

    Restricted Stock Unit

    2009-12-31−25,000→ 119,171 total
    From: 2009-12-31→ BJCT Common Stock (25,000 underlying)
Holdings

  • BJCT Common Stock

    (indirect: By 401(k))
    85,741
Footnotes (6)
  • [F1]This amendment is to add an additional 25,000 shares that should have been included in the Form 4 filed on January 4, 2010. Vesting pursuant to the Restricted Stock Agreement dated January 30, 2008.
  • [F2]Includes 3,581 ESPP shares.
  • [F3]Includes 12,054 shares received for Q4 2009 401(K)
  • [F4]Each Restricted Stock Unit represents a contingent right to receive one share of BJCT Common Stock.
  • [F5]No expiration date.
  • [F6]Includes Series F Preferred Stock 10,100, Warrant (right-to-buy) 1,000, Option (right-to-buy) 44,071 Restricted Stock Unit 64,000

Documents

1 file
  • 4
    primary_doc.xml

    PRIMARY DOCUMENT